![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Treatment satisfaction in adults with atopic dermatitis: a cross-sectional, population-based study examining patient and physician perspectives in the US.
Studies examining the real-world treatment satisfaction in adults with atopic dermatitis (AD) and the physicians who treat adults with AD are scarce. We sought to characterize treatment satisfaction of adults wit...
-
Article
Open AccessRacial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry
This real-world, cross-sectional study compared sociodemographic, clinical and treatment characteristics, and patient-reported outcomes (PROs) among racial/ethnic groups in patients with atopic dermatitis (AD)...
-
Article
Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five Phase III clinical trials
In adults with atopic dermatitis (AD), head and/or neck involvement is frequent, bothersome, and impacts quality of life, however, long-term topical corticosteroids (TCS) are contraindicated for this difficult...
-
Article
Open AccessValidation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis
The Atopic Dermatitis Control Tool (ADCT©) is a brief patient self-administered instrument designed and validated to assess atopic dermatitis (AD) control; six AD symptoms and impacts are evaluated over the pa...
-
Article
Open AccessEconomic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Dupilumab significantly improves signs and symptoms of atopic dermatitis (AD), including pruritus, symptoms of anxiety and depression, and health-related quality of life versus placebo in adults with moderate-...
-
Article
Open AccessAchieving consensus over the assessment of clinical signs in eczema trials
-
Chapter
Demonstrating end point security in embedded systems
This chapter describes a demonstrator for end-point security in a video peripheral. The demonstrator enables a third party to securely display a message, stored on a compact flash card, on a video monitor atta...
-
Chapter and Conference Paper
Intellectual Property Protection for Embedded Sensor Nodes
Embedded Sensor Networks are deeply immersed in their environment, and are difficult to protect from abuse or theft. Yet the software contained within these remote sensors often represents years of development...
-
Chapter and Conference Paper
Offline Hardware/Software Authentication for Reconfigurable Platforms
Many Field-Programmable Gate Array (FPGA) based systems utilize third-party intellectual property (IP) in their development. When they are deployed in non-networked environments, the question raises how this I...